Max Robotics — Global Service Robot Directory + US Certification

About

Daniel Joyce is a surgeon-scientist at the forefront of advancing minimally invasive approaches to complex pancreatic and urologic oncology. His research focuses on comparing robotic and laparoscopic techniques for high-risk procedures, particularly pancreatoduodenectomy (the Whipple procedure) and distal pancreatectomy. Joyce’s landmark 2024 propensity-matched analysis of over 1,200 patients demonstrated that robotic pancreatoduodenectomy offers comparable oncologic outcomes to laparoscopic surgery, with reduced conversion rates and shorter hospital stays—findings that have reshaped surgical decision-making for pancreatic cancer. His work on postoperative pancreatic fistula, a devastating complication, has informed national quality benchmarks. With over 124 citations across his top papers, Joyce’s studies are among the most cited in the field of robotic pancreatic surgery. He has also contributed provocative commentary on the cost-effectiveness of localized prostate cancer treatments, challenging the field to balance technological “advances” with patient value. A graduate of the Mayo Clinic and now at the University of Michigan, Joyce is a rising leader in surgical outcomes research, dedicated to evidence-based refinement of minimally invasive techniques.